agilon health, inc.
AGL
$1.20
-$0.01-0.83%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -5.92% | -4.45% | 44.20% | 27.72% | 38.64% |
| Total Other Revenue | -7.42% | -8.10% | 27.99% | -5.02% | 69.01% |
| Total Revenue | -5.92% | -4.46% | 44.16% | 27.63% | 38.69% |
| Cost of Revenue | -0.22% | -3.09% | 35.61% | 37.73% | 42.98% |
| Gross Profit | -262.94% | -32.45% | 59.68% | -274.18% | -41.05% |
| SG&A Expenses | -18.30% | -11.59% | -7.39% | -14.42% | -13.26% |
| Depreciation & Amortization | 23.90% | 17.66% | 37.15% | 52.59% | 38.05% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.94% | -3.40% | 33.33% | 34.59% | 38.90% |
| Operating Income | -172.88% | -353.18% | 36.30% | -236.07% | -46.69% |
| Income Before Tax | -244.88% | -154.34% | 37.27% | -461.82% | -102.27% |
| Income Tax Expenses | -85.13% | 247.37% | 558.05% | -148.76% | -61.14% |
| Earnings from Continuing Operations | -240.39% | -158.15% | 36.32% | -428.30% | -91.33% |
| Earnings from Discontinued Operations | -- | 250.85% | 101.01% | 87.47% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -100.00% | -- | -143.48% |
| Net Income | -240.17% | 299.74% | 54.09% | -274.14% | -83.19% |
| EBIT | -172.88% | -353.18% | 36.30% | -236.07% | -46.69% |
| EBITDA | -196.94% | -1,460.68% | 38.48% | -257.30% | -41.12% |
| EPS Basic | -238.07% | 297.97% | 54.72% | -268.77% | -82.84% |
| Normalized Basic EPS | -252.13% | -121.43% | 40.12% | -448.44% | -96.92% |
| EPS Diluted | -238.07% | 297.97% | 54.54% | -251.62% | -78.04% |
| Normalized Diluted EPS | -252.13% | -121.43% | 40.12% | -448.44% | -96.92% |
| Average Basic Shares Outstanding | 0.62% | 0.98% | 1.37% | 1.43% | 0.23% |
| Average Diluted Shares Outstanding | 0.62% | 0.98% | 1.37% | 1.43% | 0.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |